Diffusion Kurtosis Imaging to Assess Response to Treatment in Hypervascular Hepatocellular Carcinoma

The objective of our study was to compare diffusion kurtosis imaging (DKI) with conventional diffusion-weighted imaging (DWI) for assessing the response to treatment in hypervascular hepatocellular carcinoma (HCC). Sixty-two consecutive patients with treated or untreated hypervascular HCC underwent...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of roentgenology (1976) Vol. 204; no. 5; pp. W543 - W549
Main Authors Goshima, Satoshi, Kanematsu, Masayuki, Noda, Yoshifumi, Kondo, Hiroshi, Watanabe, Haruo, Bae, Kyongtae T.
Format Journal Article
LanguageEnglish
Published United States 01.05.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The objective of our study was to compare diffusion kurtosis imaging (DKI) with conventional diffusion-weighted imaging (DWI) for assessing the response to treatment in hypervascular hepatocellular carcinoma (HCC). Sixty-two consecutive patients with treated or untreated hypervascular HCC underwent MRI of the liver including DKI (b values of 0, 100, 500, 1000, 1500, and 2000 s/mm(2)). The mean kurtosis (MK) and apparent diffusion coefficient (ADC) values of the hepatic parenchyma and of the HCCs were computed. The detectability of viable HCC based on MK and ADC values was compared. We also assessed the correlation between Child-Pugh grades and MK or ADC values. For a total of 112 HCC nodules (viable, n = 63; nonviable, n = 49), the MK value was significantly higher for the viable group (mean ± SD, 0.81 ± 0.11) than for the non-viable group (0.57 ± 0.11) (p < 0.001). The mean ADC value was significantly lower for the viable group (1.44 ± 0.42 × 10(-3) mm(2)/s) than for the nonviable group (1.94 ± 0.52 × 10(-3) mm(2)/s) (p < 0.001). The sensitivity, specificity, and AUC of the ROC curve for the assessment of HCC viability were greater (p < 0.001) using MK (85.7%, 98.0%, and 0.95, respectively; cutoff value = 0.710) than using ADC (79.6%, 68.3%, and 0.77, respectively; cutoff value = 1.535 × 10(-3) mm(2)/s). Although the ADC of hepatic parenchyma was lower in patients with Child-Pugh grade B or C disease than in those with grade A disease (p = 0.02), no significant difference in MK (p = 0.45) was found among the Child-Pugh grades. DKI can be a new option for the assessment of posttherapeutic response in HCC.
AbstractList The objective of our study was to compare diffusion kurtosis imaging (DKI) with conventional diffusion-weighted imaging (DWI) for assessing the response to treatment in hypervascular hepatocellular carcinoma (HCC). Sixty-two consecutive patients with treated or untreated hypervascular HCC underwent MRI of the liver including DKI (b values of 0, 100, 500, 1000, 1500, and 2000 s/mm(2)). The mean kurtosis (MK) and apparent diffusion coefficient (ADC) values of the hepatic parenchyma and of the HCCs were computed. The detectability of viable HCC based on MK and ADC values was compared. We also assessed the correlation between Child-Pugh grades and MK or ADC values. For a total of 112 HCC nodules (viable, n = 63; nonviable, n = 49), the MK value was significantly higher for the viable group (mean ± SD, 0.81 ± 0.11) than for the non-viable group (0.57 ± 0.11) (p < 0.001). The mean ADC value was significantly lower for the viable group (1.44 ± 0.42 × 10(-3) mm(2)/s) than for the nonviable group (1.94 ± 0.52 × 10(-3) mm(2)/s) (p < 0.001). The sensitivity, specificity, and AUC of the ROC curve for the assessment of HCC viability were greater (p < 0.001) using MK (85.7%, 98.0%, and 0.95, respectively; cutoff value = 0.710) than using ADC (79.6%, 68.3%, and 0.77, respectively; cutoff value = 1.535 × 10(-3) mm(2)/s). Although the ADC of hepatic parenchyma was lower in patients with Child-Pugh grade B or C disease than in those with grade A disease (p = 0.02), no significant difference in MK (p = 0.45) was found among the Child-Pugh grades. DKI can be a new option for the assessment of posttherapeutic response in HCC.
The objective of our study was to compare diffusion kurtosis imaging (DKI) with conventional diffusion-weighted imaging (DWI) for assessing the response to treatment in hypervascular hepatocellular carcinoma (HCC).OBJECTIVEThe objective of our study was to compare diffusion kurtosis imaging (DKI) with conventional diffusion-weighted imaging (DWI) for assessing the response to treatment in hypervascular hepatocellular carcinoma (HCC).Sixty-two consecutive patients with treated or untreated hypervascular HCC underwent MRI of the liver including DKI (b values of 0, 100, 500, 1000, 1500, and 2000 s/mm(2)). The mean kurtosis (MK) and apparent diffusion coefficient (ADC) values of the hepatic parenchyma and of the HCCs were computed. The detectability of viable HCC based on MK and ADC values was compared. We also assessed the correlation between Child-Pugh grades and MK or ADC values.SUBJECTS AND METHODSSixty-two consecutive patients with treated or untreated hypervascular HCC underwent MRI of the liver including DKI (b values of 0, 100, 500, 1000, 1500, and 2000 s/mm(2)). The mean kurtosis (MK) and apparent diffusion coefficient (ADC) values of the hepatic parenchyma and of the HCCs were computed. The detectability of viable HCC based on MK and ADC values was compared. We also assessed the correlation between Child-Pugh grades and MK or ADC values.For a total of 112 HCC nodules (viable, n = 63; nonviable, n = 49), the MK value was significantly higher for the viable group (mean ± SD, 0.81 ± 0.11) than for the non-viable group (0.57 ± 0.11) (p < 0.001). The mean ADC value was significantly lower for the viable group (1.44 ± 0.42 × 10(-3) mm(2)/s) than for the nonviable group (1.94 ± 0.52 × 10(-3) mm(2)/s) (p < 0.001). The sensitivity, specificity, and AUC of the ROC curve for the assessment of HCC viability were greater (p < 0.001) using MK (85.7%, 98.0%, and 0.95, respectively; cutoff value = 0.710) than using ADC (79.6%, 68.3%, and 0.77, respectively; cutoff value = 1.535 × 10(-3) mm(2)/s). Although the ADC of hepatic parenchyma was lower in patients with Child-Pugh grade B or C disease than in those with grade A disease (p = 0.02), no significant difference in MK (p = 0.45) was found among the Child-Pugh grades.RESULTSFor a total of 112 HCC nodules (viable, n = 63; nonviable, n = 49), the MK value was significantly higher for the viable group (mean ± SD, 0.81 ± 0.11) than for the non-viable group (0.57 ± 0.11) (p < 0.001). The mean ADC value was significantly lower for the viable group (1.44 ± 0.42 × 10(-3) mm(2)/s) than for the nonviable group (1.94 ± 0.52 × 10(-3) mm(2)/s) (p < 0.001). The sensitivity, specificity, and AUC of the ROC curve for the assessment of HCC viability were greater (p < 0.001) using MK (85.7%, 98.0%, and 0.95, respectively; cutoff value = 0.710) than using ADC (79.6%, 68.3%, and 0.77, respectively; cutoff value = 1.535 × 10(-3) mm(2)/s). Although the ADC of hepatic parenchyma was lower in patients with Child-Pugh grade B or C disease than in those with grade A disease (p = 0.02), no significant difference in MK (p = 0.45) was found among the Child-Pugh grades.DKI can be a new option for the assessment of posttherapeutic response in HCC.CONCLUSIONDKI can be a new option for the assessment of posttherapeutic response in HCC.
Author Kondo, Hiroshi
Goshima, Satoshi
Kanematsu, Masayuki
Bae, Kyongtae T.
Noda, Yoshifumi
Watanabe, Haruo
Author_xml – sequence: 1
  givenname: Satoshi
  surname: Goshima
  fullname: Goshima, Satoshi
  organization: Department of Radiology, Gifu University Hospital, 1-1 Yanagido, 501-1194 Gifu, Japan
– sequence: 2
  givenname: Masayuki
  surname: Kanematsu
  fullname: Kanematsu, Masayuki
  organization: Department of Radiology, Gifu University Hospital, 1-1 Yanagido, 501-1194 Gifu, Japan
– sequence: 3
  givenname: Yoshifumi
  surname: Noda
  fullname: Noda, Yoshifumi
  organization: Department of Radiology, Gifu University Hospital, 1-1 Yanagido, 501-1194 Gifu, Japan
– sequence: 4
  givenname: Hiroshi
  surname: Kondo
  fullname: Kondo, Hiroshi
  organization: Department of Radiology, Gifu University Hospital, 1-1 Yanagido, 501-1194 Gifu, Japan
– sequence: 5
  givenname: Haruo
  surname: Watanabe
  fullname: Watanabe, Haruo
  organization: Department of Radiology, Gifu University Hospital, 1-1 Yanagido, 501-1194 Gifu, Japan
– sequence: 6
  givenname: Kyongtae T.
  surname: Bae
  fullname: Bae, Kyongtae T.
  organization: Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25905960$$D View this record in MEDLINE/PubMed
BookMark eNptkE1r3DAQhkVJaTZJbz0XH3uot_rW-rhsPjZtoBAS6E3I9iio2JKrkQP59_Xm41J6epnhmZfhOSFHMUUg5BOja86Z_Lb9frtmcs0EF-odWTEldS2YZEdkRYVm9YaKX8fkBPE3pdRsGvOBHHPVUNVouiL9efB-xpBi9WPOJWHA6np0DyE-VCVVW0RArG4BpxQRDqu7DK6MEEsVYrV_miA_OuzmweVqD5MrqYNheB53LnchptGdkffeDQgfX_OU3F9e3O329c3Pq-vd9qbuhDKlNsAp7XW7TF3Tqp5J4bXQLTWGes611qbzIAVw6XvXNK2EnnttmGi157IXp-TLS--U058ZsNgx4OEdFyHNaJk2amNYo9SCfn5F53aE3k45jC4_2TczC8BfgC4nxAzedqG4sogq2YXBMmoP-u2i3y7xrH85-vrP0Vvvf_G_tUyGgQ
CitedBy_id crossref_primary_10_1007_s10334_020_00846_4
crossref_primary_10_1016_j_ejrad_2020_108974
crossref_primary_10_1002_jmri_25696
crossref_primary_10_1016_j_rineng_2023_100928
crossref_primary_10_1002_nbm_4496
crossref_primary_10_1186_s13027_022_00441_3
crossref_primary_10_1002_mp_13238
crossref_primary_10_1007_s13246_019_00773_2
crossref_primary_10_1016_j_acra_2021_04_016
crossref_primary_10_1177_1756284819885052
crossref_primary_10_1177_0284185119889566
crossref_primary_10_2147_CMAR_S254371
crossref_primary_10_2478_raon_2019_0031
crossref_primary_10_1093_bjr_tqae024
crossref_primary_10_1002_nbm_4680
crossref_primary_10_1016_j_jvir_2019_05_030
crossref_primary_10_18632_oncotarget_17491
crossref_primary_10_1002_jmri_26058
crossref_primary_10_1016_j_mric_2015_08_003
crossref_primary_10_1002_jmri_25527
crossref_primary_10_1186_s12880_021_00661_w
crossref_primary_10_1002_jmri_25768
crossref_primary_10_1148_radiol_2017170995
crossref_primary_10_5114_pjr_2023_131911
crossref_primary_10_1016_j_hpb_2017_09_004
crossref_primary_10_1016_j_mri_2017_11_001
crossref_primary_10_1148_radiol_2017170515
crossref_primary_10_1177_0284185119840219
crossref_primary_10_1177_0284185119878362
crossref_primary_10_1007_s00261_015_0602_x
crossref_primary_10_1002_jmri_24985
crossref_primary_10_1002_jmri_24982
crossref_primary_10_1097_RCT_0000000000001176
crossref_primary_10_1002_jmri_25793
crossref_primary_10_1002_jmri_26563
crossref_primary_10_1186_s12967_018_1714_1
crossref_primary_10_1186_s12876_022_02517_1
crossref_primary_10_1007_s12029_017_9969_y
crossref_primary_10_4329_wjr_v8_i11_857
crossref_primary_10_3390_jcm10122641
crossref_primary_10_1007_s40139_019_00204_7
crossref_primary_10_1097_RMR_0000000000000144
crossref_primary_10_1155_2017_6053879
crossref_primary_10_1002_mrm_29457
crossref_primary_10_3390_diagnostics5040513
crossref_primary_10_4240_wjgs_v14_i10_1150
crossref_primary_10_1002_jmri_27569
crossref_primary_10_1007_s00330_017_5094_3
crossref_primary_10_2478_raon_2019_0004
crossref_primary_10_1007_s00261_016_0984_4
crossref_primary_10_1186_s13027_021_00393_0
crossref_primary_10_1016_j_mri_2021_05_002
crossref_primary_10_2463_mrms_rev_2022_0107
crossref_primary_10_1016_j_ejim_2020_06_004
crossref_primary_10_3390_cancers14235860
crossref_primary_10_1007_s00330_017_5245_6
crossref_primary_10_1097_MD_0000000000020795
crossref_primary_10_1186_s41747_024_00448_y
crossref_primary_10_1186_s40644_019_0213_9
crossref_primary_10_2174_1573405616666201130101229
crossref_primary_10_1038_s41598_020_65956_4
crossref_primary_10_1177_0284185117706608
crossref_primary_10_1016_j_ejmp_2019_09_238
crossref_primary_10_1038_s41598_017_11808_7
crossref_primary_10_1016_j_crad_2019_10_015
Cites_doi 10.1002/mrm.20508
10.1148/radiol.12112290
10.1002/jmri.21316
10.2214/AJR.07.2086
10.1002/nbm.1518
10.1148/radiol.09090819
10.1002/bjs.1800600817
10.1002/jmri.24234
10.1148/radiol.11102277
10.1148/radiol.2493080080
10.1002/nbm.1610
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.2214/AJR.14.13235
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1546-3141
EndPage W549
ExternalDocumentID 25905960
10_2214_AJR_14_13235
Genre Journal Article
GroupedDBID ---
-DD
.55
.GJ
1CY
1KJ
23M
2WC
34G
39C
3O-
53G
5GY
5RE
AAEJM
AAWTL
AAYXX
ABOCM
ADBBV
AENEX
AFFNX
AI.
AJJEV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C1A
CITATION
CS3
DIK
E3Z
EBS
EJD
F5P
GX1
H13
J5H
L7B
LSO
MJL
P2P
SJN
TR2
TRR
TWZ
UDS
VH1
W2D
W8F
WH7
WOQ
X7M
YJK
YQI
YQJ
ZGI
ZVN
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c357t-7e200d6bc35c9b5d143f636b0770f226667cfe43e24fda99b4ed2f6713b6f24d3
ISSN 0361-803X
1546-3141
IngestDate Fri Jul 11 02:33:35 EDT 2025
Mon Jul 21 06:01:36 EDT 2025
Thu Apr 24 23:10:43 EDT 2025
Tue Jul 01 01:22:22 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords HCC
diffusion
kurtosis
MRI
liver
hepatocellular carcinoma
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c357t-7e200d6bc35c9b5d143f636b0770f226667cfe43e24fda99b4ed2f6713b6f24d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 25905960
PQID 1675871955
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1675871955
pubmed_primary_25905960
crossref_citationtrail_10_2214_AJR_14_13235
crossref_primary_10_2214_AJR_14_13235
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-05-00
2015-May
20150501
PublicationDateYYYYMMDD 2015-05-01
PublicationDate_xml – month: 05
  year: 2015
  text: 2015-05-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle American journal of roentgenology (1976)
PublicationTitleAlternate AJR Am J Roentgenol
PublicationYear 2015
References Le Bihan D. (R2) 1991; 7
R3
R4
R5
R6
R7
R9
Child CG (R8) 1964; 1
R10
R12
R11
R13
R1
References_xml – ident: R3
  doi: 10.1002/mrm.20508
– ident: R10
  doi: 10.1148/radiol.12112290
– ident: R1
  doi: 10.1002/jmri.21316
– volume: 1
  start-page: 1
  year: 1964
  ident: R8
  publication-title: Major Probl Clin Surg
– ident: R11
  doi: 10.2214/AJR.07.2086
– volume: 7
  start-page: 1
  year: 1991
  ident: R2
  publication-title: Magn Reson Q
– ident: R4
  doi: 10.1002/nbm.1518
– ident: R7
  doi: 10.1148/radiol.09090819
– ident: R9
  doi: 10.1002/bjs.1800600817
– ident: R13
  doi: 10.1002/jmri.24234
– ident: R6
  doi: 10.1148/radiol.11102277
– ident: R12
  doi: 10.1148/radiol.2493080080
– ident: R5
  doi: 10.1002/nbm.1610
SSID ssj0007897
Score 2.427692
Snippet The objective of our study was to compare diffusion kurtosis imaging (DKI) with conventional diffusion-weighted imaging (DWI) for assessing the response to...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage W543
SubjectTerms Aged
Aged, 80 and over
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - therapy
Diffusion Magnetic Resonance Imaging - methods
Female
Humans
Image Interpretation, Computer-Assisted
Liver Neoplasms - pathology
Liver Neoplasms - therapy
Male
Neovascularization, Pathologic - pathology
Neovascularization, Pathologic - therapy
Prospective Studies
Sensitivity and Specificity
Treatment Outcome
Title Diffusion Kurtosis Imaging to Assess Response to Treatment in Hypervascular Hepatocellular Carcinoma
URI https://www.ncbi.nlm.nih.gov/pubmed/25905960
https://www.proquest.com/docview/1675871955
Volume 204
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWIiEuFW_KS0aCU5WS2I6THFGBLkXtAW3FcorWiS1WsEmVTQ7wm_iRzNiJN4u2UuESrbMeR8lM5uHMfEPIK8UjxpSSgSoED4QGPZhlRgYmZFnBy1RyjrXDZ-dyeiFO5_F8Mvk9ylrqWnVU_NpZV_I_XIVzwFeskv0HzvpF4QT8Bv7CETgMx2vx-N3SmA63uw4_dU1bI7bIx5VrOwQupfueixv0mAVrW2TMfFo5QlxBCNr4TNQp2KW2xn18OzzGHkNV3WvtAaZ2-LwzwptoalgOkV4tlhPCPoHrMdpfOKnX35arhdt9bnHgdfyiQsDYdedqhtaLn913_-d5XVqar0hhutWGCvuPWIO5bPxq_bZFFG-SBH25VgTm0TYDBkPUa18hwSg4JKxBPTPXnriXw3ikbL_EDuGpN9wwzHYZBcYigeAUp5_BLBxB9O3wUbaxt_-yiT5TEWIkpM-BGqKk3FLfIDcZBCXYL-NkvkkoSlLbysffmCuzQOo342tvO0BXRDXWu5ndIft9WELfOhm7Sya6ukdunfWJF_dJ6UWNDqJGe1GjbU2dqNFB1PCUFzW6rOiWqNFtUaNe1B6Qiw_vZ8fToG_QERQ8Ttog0fA2llLBqMhUXILvbSSXKkyS0IBfL2VSGC24ZsKUiyxTQpfMyCTiShomSv6Q7FV1pR8TmnLOE1GAyYMIPw5DlSx4FOlUaZirUn1ADoenlhc9ej02UfmR7-LQAXntZ1861JYr5r0cGJCDWsUbB9Gvu3UeYSCdRFkMcx45zviVWJxh06rwyTWv8pTc3rwBz8he23T6ObiyrXphJegP9F6fFg
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diffusion+Kurtosis+Imaging+to+Assess+Response+to+Treatment+in+Hypervascular+Hepatocellular+Carcinoma&rft.jtitle=American+journal+of+roentgenology+%281976%29&rft.au=Goshima%2C+Satoshi&rft.au=Kanematsu%2C+Masayuki&rft.au=Noda%2C+Yoshifumi&rft.au=Kondo%2C+Hiroshi&rft.date=2015-05-01&rft.issn=0361-803X&rft.eissn=1546-3141&rft.volume=204&rft.issue=5&rft.spage=W543&rft.epage=W549&rft_id=info:doi/10.2214%2FAJR.14.13235&rft.externalDBID=n%2Fa&rft.externalDocID=10_2214_AJR_14_13235
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0361-803X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0361-803X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0361-803X&client=summon